Read + Share
Colligan SH, Amitrano AM, Zollo RA, Peresie J, et al. Inhibiting the biogenesis of myeloid-derived suppressor cells enhances
immunotherapy efficacy against mammary tumor progression. J Clin Invest 2022;132:e158661.
PMID: 36453551
|
 |
|
Colligan SH, Amitrano AM, Zollo RA, Peresie J, et al. Inhibiting the biogenesis of myeloid-derived suppressor cells enhances
immunotherapy efficacy against mammary tumor progression. J Clin Invest 2022;132:e158661.
PMID: 36453551
|
|
|
|